The relevant question is whether a particular product and activity comply with the requirements applicable to its classification, representation, and intended use
Misuse and abuse of CNS stimulants, including VYVANSE, can result in overdose and death (5.1, 9.2, 10): Before prescribing VYVANSE, assess each patient's risk for abuse, misuse, and addiction
Avoid Planning Mistakes Completely With our dietitian-designed meal plans, you'll never have to wonder if you're eating right for GLP-1 success
doi: 10.1016/j.cmet.2016.10.008 41 EspinosaVJhingranADuttaOKasaharaSDonnellyRDuPet al
It can provide visible and often immediate benefits, including brightening the complexion and reducing the appearance of dark spots and other forms of hyperpigmentation
1 In 2017, Novo Nordisk introduced semaglutide (Ozempic), a long-acting GLP-1 RA used to improve glycemic control, and later approved in 2021 under the brand name Wegovy as an injection to promote weight loss in individuals with obesity and overweight